146 related articles for article (PubMed ID: 1763142)
1. Importance of pharmacologic control in PET studies: effects of thiothixene and haloperidol on cerebral glucose utilization in chronic schizophrenia.
Bartlett EJ; Wolkin A; Brodie JD; Laska EM; Wolf AP; Sanfilipo M
Psychiatry Res; 1991 Oct; 40(2):115-24. PubMed ID: 1763142
[TBL] [Abstract][Full Text] [Related]
2. Cerebral metabolic patterns in chronic and recent-onset schizophrenia.
Desco M; Gispert JD; Reig S; Sanz J; Pascau J; Sarramea F; Benito C; Santos A; Palomo T; Molina V
Psychiatry Res; 2003 Feb; 122(2):125-35. PubMed ID: 12714176
[TBL] [Abstract][Full Text] [Related]
3. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol.
Holcomb HH; Cascella NG; Thaker GK; Medoff DR; Dannals RF; Tamminga CA
Am J Psychiatry; 1996 Jan; 153(1):41-9. PubMed ID: 8540590
[TBL] [Abstract][Full Text] [Related]
4. Neuroleptic effects on regional brain metabolism in first episode schizophrenics.
Cleghorn JM; Szechtman H; Garnett ES; Brown GM; Nahmias C; Szechtman B; Kaplan R; Franco S
Schizophr Res; 1991 Oct; 5(3):208-9. PubMed ID: 1684720
[No Abstract] [Full Text] [Related]
5. Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia.
Buchsbaum MS; Potkin SG; Marshall JF; Lottenberg S; Teng C; Heh CW; Tafalla R; Reynolds C; Abel L; Plon L
Neuropsychopharmacology; 1992 May; 6(3):155-63. PubMed ID: 1599606
[TBL] [Abstract][Full Text] [Related]
6. The effect of antipsychotic medication on relative cerebral blood perfusion in schizophrenia: assessment with technetium-99m hexamethyl-propyleneamine oxime single photon emission computed tomography.
Miller DD; Rezai K; Alliger R; Andreasen NC
Biol Psychiatry; 1997 Mar; 41(5):550-9. PubMed ID: 9046987
[TBL] [Abstract][Full Text] [Related]
7. Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration.
Volkow ND; Brodie JD; Wolf AP; Angrist B; Russell J; Cancro R
J Neurol Neurosurg Psychiatry; 1986 Oct; 49(10):1199-1202. PubMed ID: 3491182
[TBL] [Abstract][Full Text] [Related]
8. Mutability and relationship between positive and negative symptoms during neuroleptic treatment in schizophrenia.
Tandon R; Goldman RS; Goodson J; Greden JF
Biol Psychiatry; 1990 Jun; 27(12):1323-6. PubMed ID: 2364120
[No Abstract] [Full Text] [Related]
9. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography.
Wolkin A; Jaeger J; Brodie JD; Wolf AP; Fowler J; Rotrosen J; Gomez-Mont F; Cancro R
Am J Psychiatry; 1985 May; 142(5):564-71. PubMed ID: 3872603
[TBL] [Abstract][Full Text] [Related]
10. Hypometabolism in olfactory cortical projection areas of male patients with schizophrenia: an initial positron emission tomography study.
Bertollo DN; Cowen MA; Levy AV
Psychiatry Res; 1996 Mar; 60(2-3):113-6. PubMed ID: 8723301
[TBL] [Abstract][Full Text] [Related]
11. Patterns of metabolic activity in the treatment of schizophrenia.
Brodie JD; Christman DR; Corona JF; Fowler JS; Gomez-Mont F; Jaeger J; Micheels PA; Rotrosen J; Russell JA; Volkow ND
Ann Neurol; 1984; 15 Suppl():S166-9. PubMed ID: 6611117
[TBL] [Abstract][Full Text] [Related]
12. Haloperidol and thiothixene in the long-term treatment of chronic schizophrenic outpatients in an urban community: social and vocational adjustment.
Engelhardt DM; Rudorfer L; Rosen B
J Clin Psychiatry; 1978 Dec; 39(12):834-40. PubMed ID: 721787
[TBL] [Abstract][Full Text] [Related]
13. Haloperidol and thiothixene in the long-term treatment of chronic schizophrenic outpatients in an urban community: social and vocational adjustment.
Slotnick VB
J Clin Psychiatry; 1980 Mar; 41(3):105-6. PubMed ID: 7354016
[No Abstract] [Full Text] [Related]
14. Apomorphine effects on brain metabolism in neuroleptic-naive schizophrenic patients.
Cleghorn JM; Szechtman H; Garnett ES; Nahmias C; Brown GM; Kaplan RD; Szechtman B; Franco S
Psychiatry Res; 1991 Oct; 40(2):135-53. PubMed ID: 1763143
[TBL] [Abstract][Full Text] [Related]
15. The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia.
Buchsbaum MS
Schizophr Bull; 1990; 16(3):379-89. PubMed ID: 2287929
[TBL] [Abstract][Full Text] [Related]
16. No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone.
Nordström AL; Farde L; Eriksson L; Halldin C
Psychiatry Res; 1995 Aug; 61(2):67-83. PubMed ID: 7480390
[TBL] [Abstract][Full Text] [Related]
17. Psychopharmacological correlates of post-psychotic depression: a double-blind investigation of haloperidol vs thiothixene in outpatient schizophrenia.
Abuzzahab FS; Zimmerman RL
J Clin Psychiatry; 1982 Mar; 43(3):105-10. PubMed ID: 7037757
[TBL] [Abstract][Full Text] [Related]
18. A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography.
Potkin SG; Alva G; Fleming K; Anand R; Keator D; Carreon D; Doo M; Jin Y; Wu JC; Fallon JH
Am J Psychiatry; 2002 Feb; 159(2):227-37. PubMed ID: 11823264
[TBL] [Abstract][Full Text] [Related]
19. Thrombocytopenia associated with chlorpromazine, haloperidol and thiothixene: a case report.
Balon R; Berchou R; Zethelius M
Can J Psychiatry; 1987 Mar; 32(2):149-50. PubMed ID: 3567823
[TBL] [Abstract][Full Text] [Related]
20. Rapid tranquilization: a comparative study of thiothixene and haloperidol.
Kelwala S; Ban TA; Berney SA; Wilson WH
Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):77-83. PubMed ID: 6145189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
